Robert J. Paradiso Partner

Roseland
T 973.597.2404 | F 973.597.2405



Chair, Life Sciences Patent Practice

Robert is an intellectual property attorney focused on the life sciences industry. Over the course of his career, he has had the privilege of counseling clients on the discovery, design and protection of many successful therapeutic and diagnostic products with important commercial and humanitarian benefits.

Robert is a registered pharmacist and is able to speak the same language as the researchers, managers and investors with whom he interacts daily. He is particularly adept at analyzing complex issues and effectively communicating solutions that achieve his clients’ goals, whether it be raising capital, closing the deal or obtaining a bet-the-company patent. As a testament to his reputation and recognition in the field, Robert has served as an Adjunct Professor at Rutgers University Law School for the past five years, where he teaches patent drafting and prosecution.

Robert is the Chair of the Life Sciences Patent practice at Lowenstein Sandler and has significant experience in virtually all aspects of intellectual property, including patent prosecution, noninfringement, patentability, litigation, freedom to operate and technology transfer. He also regularly advises clients on product acquisition and divestiture, joint ventures and alliances, technology licensing, outsourcing, and other technology-related transactions.


Representative Engagements

Obtained a groundbreaking patent that is listed in the FDA Orange Book for a tamper resistant formulation of an FDA-approved narcotic analgesic.
Obtained Orange Book listed patents for a specialty pharmaceutical company specializing in acute hospital care. The patents encompass four currently marketed formulations of an injectable antihypertensive product and were the driving force for the eventual acquisition of the company.
Obtained multiple patents covering a Phase III injectable product for the treatment of adverse effects of chemotherapy.
View More...

Other Distinctions

  • Chambers USA: America’s Leading Lawyers for Business (2012-2013) – Sources praise Robert for having the ability to “spin gold out of hay” and being “very smart, easy to deal with and a practical strategic thinker.”

Publications

Laws of Nature: Myriad and the Prometheus Impact
Bloomberg Life Sciences Law & Industry Report, June 1, 2012
Robert Paradiso
Drafting Method-of-Treatment Claims
New Jersey Law Journal, April 11, 2011
Robert Paradiso
District Court Holds Myriad’s Gene Patents Invalid
Metropolitan Corporate Counsel, June 2010
Robert Paradiso
View More...

Press Mentions

Lowenstein Sandler represented Celldex Therapeutics in its $191 million (gross) underwritten public offering of common stock, which closed on December 10, 2013. Jefferies LLC and Leerink Swann LLC acted as joint book-running managers of the offering. Guggenheim Securities, Oppenheimer & Co. Inc., Wedbush PacGrow Life Sciences, Brean Capital, LLC, Cantor Fitzgerald & Co. and ROTH Capital Partners acted as co-managers of the offering. The Lowenstein Sandler team was led by Anthony O. PergolaMichael J. Lerner and Alan Wovsaniker, with Meredith PrithvirajJared Heady and Robert Paradiso. Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Celldex’s pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body’s immune response. , December 10, 2013
Robert J. Paradiso spotlighted as a contributor for his insights on intellectual property rights and claims that have arisen as a result of the human genome project. , RegentAtlantic Capital, LLC , December 2007
Robert J. Paradiso comments on the Patent Reform Act of 2007 and key concerns among biotechnology companies. , NJBiz , September 13, 2007

Events

December 2, 2014
Lowenstein Sandler’s Alumni CLE Day


Related Areas

Corporate
Life Sciences
Patents
The Tech Group

Education


St. John's University School of Law ( J.D. , 1994 )
Long Island University ( B.S. , 1990 ) , Pharmacy

Bar Admissions


New York
New Jersey
United States Patent and Trademark Office